Open Pharma quarterly update: January–March 2025. Read about what we've been up to this quarter!

Learn why you should create a Plain Language Summary (PLS), the different types, and how to write and develop your PLS for publication.

This week, we encourage readers to comment on draft OABP recommendations from NISO and complete a survey exploring how to make PLS clearer and more accessible. We also read guidance on how to make PLS accessible in APAC, and we consider when and how to retract an article. We review insights on transparent peer review based on experiences at the European Journal of Higher Education and ask if pharma is ready to rethink implementation for patient centricity. Finally, we listen to the latest MAPS Elevate podcast, which explores how to improve your journal selection process.

This week, we spotlight a call for increased transparency in pharmacoepidemiology research and the barriers to publishing PLS. We read about the intersection of AI and open science principles, and we ...

This week, we learn about the importance of plain language summaries from the ISMPP podcast, In Plain Cite. We signpost an upcoming webinar about Registered Reports, and we feature a nine-part trainin...

Despite clinical efficacy and cost-effectiveness, time to reimbursement for chimeric antigen receptor (CAR) T-cell therapies varies greatly across Europe. We examined these differences, and quantif...